Immunohistochemical staining revealed that NDV+liposomal doxorubicin‐treated tumours expressed higher P53 due to increased apoptotic and necrotic tumour cells and lower Ki67 expression as proliferative markers (Figure 5II). This evidence concerns the gene TP53 and neoplasm.